The Declaration was written by 20 experts from diabetes and Bariatric Surgery who have made a number of recommendations on the use of weight loss surgery as a treatment option profitable for very obese people with type 2 diabetes.
The combination of obesity and type 2 diabetes looms as the biggest problem of the epidemic and of public health in human history. Type 2 diabetes is a disease grows today with some 300 million people around the world and 450 million inhabitants, the forecasts will have diabetes in 2030.
Declaration, it has been increasingly clear that the health of type 2 diabetic obese people, including its control of glucose and other co-morbidities associated with obesity (conditions) can benefit greatly from bariatric procedure in certain circumstances.
The Israeli army working group in the epidemiology and prevention of diabetes called the Group of experts with specific objectives:
Develop recommendations for patient barriers physicians practices identify selection and management of health policies suggests a surgical access to ensure equitable access to identify priorities for surgical intervention for research.
Co-Chair Professor Sir George Alberti, Senior researcher, Imperial College London, said: "Bariatric intervention is a cost-effective therapy for type 2 diabetes and obesity with an acceptable safety profile and health". For type 2 diabetes of very obese people bariatric surgery should be considered, well before administration instead of being retained as a last resort. "It must be made of the type 2 diabetes treatment protocols." He also noted that the points of action of the Court may be lower in Asian populations because of their increased risk of diabetes and heart disease.
Professor Paul Zimmet AO, Director Emeritus, heart of Baker IDI and Diabetes Institute, Melbourne, and co-Chairman, said: "Bariatric Surgery is a treatment that can be recommended for people with type 2 diabetes and obesity do not reach the objectives of recommended treatment with the existing medical treatments."especially when there are other main co-morbidities such as hypertension, hypercholesterolemia or sleep apnea. Surgery should be an option accepted by people with diabetes type 2 and a (BMI) BMI of 35 or more. Procedures must be carried out in the guidelines accepted and require an adequate multidisciplinary evaluation before surgery and sustained attention. "
Professor Francesco Rubino, Chief of program of gastrointestinal metabolic surgery at New York-Presbyterian Hospital/Weill Cornell Medical Center and the global Director of the 2nd Congress of Interventional therapies for type 2 Diabetes, said: "this is the first time that the International Federation of diabetes or any major international organization has made recommendations on this therapy field is growing rapidly." He did so because of the urgent need for expert advice around the world on the use of Bariatric procedure increased use. We take note of the need for measures appropriate in education and the selection of patients and safe surgical procedures and standardized. "After surgery follow up long term is critical."
Professor John Dixon, head of the research unit of obesity, Department of general medicine, Monash University, Melbourne, said: "it is very important that the health authorities and policy makers understand that almost all severely obese patients may not achieve and maintain significant weight loss." It must be in this case with Bariatric Surgery, which can lead to diabetes remission in up to 80% of patients. "National guidelines and the registers of the need of Bariatric Surgery are developed and implemented for people with type 2 diabetes."
The Group of experts warned that the situation in low-income and middle-income countries presents intermediate special problems due to severe obesity increasing at an alarming rate. As health care resources are limited, bariatric surgery should only take place when the health budget can be afforded and experience is available for surgery and long-term follow-up.
Social Plugin